Interleukin-1β and tumour necrosis factor-α inhibit the release of [3H]-noradrenaline from mice isolated atria

Naunyn-Schmiedeberg's Archives of Pharmacology

Volumn 354, Issue 1, 1996, Pages 1-6

  Foucart, Sylvain ^a   Abadie, Claire ^b  

^a UNIVERSITÉ DE MONTRÉAL   (Canada)

^b HÔPITAL DU SACRÉ COEUR DE MONTRÉAL   (Canada)

Author keywords

Cytokines; Interleukin 1 ; Mouse atria; Noradrenaline release; Prejunctional modulation; Sympathetic nervous system; Tumor necrosis factor

Indexed keywords

DESIPRAMINE; DICLOFENAC; NORADRENALIN; OXYMETAZOLINE; PROSTAGLANDIN; PROSTAGLANDIN SYNTHASE INHIBITOR; RADIOISOTOPE; RECOMBINANT INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; RECOMBINANT INTERLEUKIN 1BETA; RECOMBINANT INTERLEUKIN 2; RECOMBINANT INTERLEUKIN 6; RECOMBINANT TUMOR NECROSIS FACTOR ALPHA;

ADRENERGIC SYSTEM; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DOSE TIME EFFECT RELATION; DRUG ANTAGONISM; ELECTROSTIMULATION; FEMALE; HEART ATRIUM; IMMUNE SYSTEM; ISOLATED HEART; MEDIATOR; MOUSE; NONHUMAN; NORADRENALIN RELEASE;

ANIMALS; CYCLOOXYGENASE INHIBITORS; DRUG INTERACTIONS; FEMALE; HEART ATRIA; INTERLEUKIN 1 RECEPTOR ANTAGONIST PROTEIN; INTERLEUKIN-1; INTERLEUKIN-2; INTERLEUKIN-6; MICE; NOREPINEPHRINE; RECOMBINANT PROTEINS; SIALOGLYCOPROTEINS; TRITIUM; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0029897341     PISSN: 00281298     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (35)

1. Ader R, Felten D, Cohen N (1990) Interactions between the brain and the immune system. Annu Rev Pharmacol Toxicol 30: 561-602
2. Bataillard A, Sassard J (1994) Cardiovascular effects of human recombinant interleukin-1β in conscious rats. Am J Physiol 266:R1148-R1153
3. Besedowsky H, Del Rey A, Sorkin E, Dinarello CA (1986) Immunoregulatory feedback between interleukin-1 and glucocorticoid hormones. Sciences 233:652-654
4. Bognar IT, Albrecht S-A, Farasaty M, Schmitt E, Seidel G, Fuder H (1994) Effects of human recombinant interleukins on stimulation-evoked noradrenaline overflow from the rat perfused spleen. Naunyn-Schmiedeberg's Arch Pharmacol 349:497-502
5. Bognar IT, Albrecht S-A, Farasaty M, Fuder H (1995) Inhibition by interleukin-1β of noradrenaline release in rat spleen: involvement of lymphocytes, NO and opioid receptors. Naunyn-Schmiedeberg's Arch Pharmacol 351:433-438
6. Eisenberg SP, Evans SP, Arend WP, Verderber E, Brewer MT, Hannum CH, Thompson RC (1990) Primary structure and functional expression from complementary DNA of a human interleukin-1 receptor antagonist. Nature (Lond) 343:341-346
7. Elenkov IJ, Kovacs K, Duda E, Stark E, Vizi ES (1992) Presynaptic inhibitory effect of TNF-alpha on the release of noradrenaline in isolated median eminence. J Neuroimmunol 41:117-120
8. Evans HG, Lewis MJ, Shah AM (1993) Interleukin-1β modulates myocardial contraction via dexamethasone sensitive production of nitric oxide. Cardiovasc Res 27:1486-1490
9. Foucart S, Wang R, Moreau P, Sauvé R, de Champlain J, Yamaguchi N, Bai L, Lu X-R (1994) Effects of Buthus Martensii Karsch scorpion venom on the release of noradrenaline from in vitro and in vivo rat preparations. Can J Physiol Pharmacol 72:855-861
10. Hanisch UK, Secto D, Quirion R (1993) Modulation of hippocampal acetylcholine release - A potent central action of interleukin-2. J Neurosci 13:3368-3374
11. Hannum CH, Wilcox CJ, Arend WP, Joslin FG, Dripps DJ, Heimjal PL, Armes LG, Sommer A, Eisenberg SP, Thompson RC (1990) Interleukin-1 receptor antagonist activity of a human interleukin-1 inhibitor. Nature (Lond) 343:336-340.
12. Hurst S, Collins SM (1993) Interleukin-1β modulation of norepinephrine release from rat myenteric nerves. Am J Physiol 264: G30-G35
13. Hurst S, Collins SM (1994) Mechanism underlying tumor necrosis factor-α suppression of norepinephrine release from rat myenteric plexus. Am J Physiol 266:G1123-G1129
14. Ichijo T, Katafuchi T, Hori T (1994) Central interleukin-1β enhances splenic sympathetic nerve activity in rats. Brain Res Bull 34: 547-553
15. Johnston H, Majewski H, Musgrave IF (1987) Involvement of cyclic nucleotides in prejunctional modulation of noradrenaline release in mouse atria. Br J Pharmacol 91:73-781
16. Junquero DC, Schini VB, Scott Burden T, Vanhoutte PM (1993) Enhanced production of nitric oxide in aortae from spontaneously hypertensive rats by interleukin-1β. Am J Hypertens 6:602-610
17. Morimoto K, Morimoto A, Nakamori T, Tan N, Minagwa T, Muramaki N (1992) Cardiovascular responses induced in free-moving rats by immune cytokines. J Physiol (Lond) 448:307-320
18. Niijima A, Hori T, Aou S, Oomura Y (1991) The effects of interleukin-1β on the activity of adrenal, splenic and renal sympathetic nerves in the rat. J Anton Nerv Syst 36:183-192
19. Oddis CV, Finkel MS (1995) Cytokine-stimulated nitric oxide production inhibits mitochondrial activity in cardiac myocytes. Biochem Biophys Res Commun 213:1002-1009
20. Okusawa S, Gelfand JA, Ikejima T, Connolly RJ, Dinarello CA (1988) Interleukin 1 induces a shock-like state in rabbits. Synergism with tumor necrosis factor and the effects of cyclooxygenase inhibition. J Clin Invest 81:1162-1172
21. Petitclerc E, Abel S, deBlois D, Poubelle PE, Marceau F (1992) Effects of interleukin-1 receptor antagonist on three types of responses to interleukin-1 in rabbit isolated blood vessels. J Cardiovasc Pharmacol 19:821-829
22. Peticlerc E, Poubelle PE, Marceau F (1994) Rapid protein synthesis and turnover is involved in interleukin-1-induced relaxation of the rabbit isolated mesenteric artery. Analysis of the arachidonate cascade. J Pharmacol Exp Ther 268:1419-1425
23. Rogauseh H, Del Rey A, Kabiersch A, Besedovsky HO (1995) Interleukin-1 increases splenic blood flow by affecting the sympathetic vasoconstrictor tonus. Am J Physiol 268:R902-R908
24. Rozanski GJ, Witt RC (1994) IL-1 inhibits β-adrenergic control of cardiac calcium current: role of L-arginine/nitric oxide pathway. Am J Physiol 267:H1753-H1758
25. Schultzberg M, Svenson SB, Undén A, Bartfai T (1987) Interleukin-1 like immunoreactivity in peripheral tissues. J Neurosci Res 18:184-187
26. Schulz R, Panas DL, Catena R, Moncada S, Olley PM, Lopaschuk GD (1995) The role of nitric oxide in cardiac depression induced by interleukin-1β and tumour necrosis factor-α. Br J Pharmacol 114:27-34
27. Schwieler JH, Kahan T, Nussberger J, Hjemdahl P (1994) Participation of prostaglandins and bradykinin in the effects of angiotensin II and converting enzyme-inhibition on sympathetic neurotransmission in vivo. Acta Physiol Scand 152:83-91
28. Smith EM (1992) Hormonal activities of cytokines. Neuroimmunoendocrinology 52:154-169
29. Starke K (1977) Regulation of noradrenaline release by presynaptic receptor systems. Rev Physiol Biochem Pharmacol 77:1-124
30. Starke K, Pescar BA, Schumacher KA, Taube HD (1977) Bradykinin and postganglionic sympathetic transmission. Naunyn Schmiedeberg's Arch Pharmacol 299:23-32
31. Takahashi H, Nishimura M, Sakamoto M, Ikegaki I, Nakanishi T, Yoshimura M (1992) Effects of interleukin-1β on blood pressure, sympathetic nerve activity, and pituitary endocrine functions in anesthetized rats. Am J Hypertens 5:224-229
32. Terao A, Oikawa M, Saito M (1993) Cytokine-induced change in hypothalamic norepinephrine turnover: involvement of corticotropin-releasing hormone and prostaglandins. Brain Res 622:257-261
33. Vriend CY, Zuo L, Dyck DG, Nance DM, Greenberg AH (1993) Central administration of interleukin-1β increases norepinephrine turnover in the spleen. Brain Res Bull 31:39-42
34. Yanagihara N, Minami K, Shirakawa F, Uezono Y, Kobayashi H, Eto S, Izumi F (1994) Stimulatory effect of IL-1β on catecholamine secretion from cultured bovine adrenal medullary cells. Biochem Biophys Res Commun 198:81-87
35. Zalcman S, Green-Johnson JM, Murray L, Nance DM, Dyck D, Anisman H, Greenberg AH (1994) Cytokine-specific central monoamine alterations induced by interleukin-1,-2 and -6. Brain Res 643:40-49